The Effects of a Cinchona Supplementation on Satiety, Weight Loss and Body Composition in a Population of Overweight/Obese Adults: A Controlled Randomized Study.
Martina ChiurazziBarbara De ConnoMariastella Di LauroBruna GuidaGilda NastiElisabetta SchianoMariano StornaiuoloGian Carlo TenoreAntonio ColantuoniEttore NovellinoPublished in: Nutrients (2023)
Obesity is a risk factor for several diseases present worldwide. Currently, dietary changes and physical activity are considered the most effective treatment to reduce obesity and its associated comorbidities. To promote weight loss, hypocaloric diets can be supported by nutraceuticals. The aim of this study was to evaluate the effects of a hypocaloric diet associated with Cinchona succirubra supplementation on satiety, body weight and body composition in obese subjects. Fifty-nine overweight/obese adults, were recruited, randomized into two groups and treated for 2 months. The first group (32 adults) was treated with a hypocaloric diet plus cinchona supplementation (the T-group); the second one (27 adults) was treated with a hypocaloric diet plus a placebo supplementation (the P-group). Anthropometric-measurements as well as bioimpedance analysis, a Zung test and biochemical parameters were evaluated at baseline and after 60 days. T-group adults showed significant improvement in nutritional status and body composition compared to those at the baseline and in the P-group. Moreover, T-group adults did not show a reduction in Cholecystokinin serum levels compared to those of P-group adults. In conclusion, our data demonstrate that a hypocaloric diet associated with cinchona supplementation is effective in inducing more significant weight loss and the re-establishment of metabolic parameters than those obtained with a hypocaloric diet.
Keyphrases
- weight loss
- body composition
- bariatric surgery
- roux en y gastric bypass
- gastric bypass
- resistance training
- physical activity
- bone mineral density
- glycemic control
- weight gain
- obese patients
- body weight
- metabolic syndrome
- double blind
- type diabetes
- clinical trial
- body mass index
- insulin resistance
- open label
- replacement therapy
- depressive symptoms